If you owned Walgreens stock (WBA), it was acquired by Sycamore Partners in August 2025, meaning your shares were bought out for $11.45 cash per share, and you also received a non-transferable "chit" or Contingent Value Right (CVR) for up to $3 more per share from the future sale of Walgreens' VillageMD clinic business, making it no longer a publicly traded stock. You no longer own shares but hold these rights, with the CVR's payout depending on how much Sycamore gets for the clinics within a few years.
Walgreens stock will cease trading, and shareholders will receive $11.45 per share plus an additional up to $3 per share from the net proceeds of any potential future sales of VillageMD, the company said.
Walgreens is being taken private
To that end, Walgreens has agreed to be bought by Sycamore Partners. The deal is expected to close in the second half of 2025, with Walgreens shareholders getting $11.45 per share in cash. That's all that investors here can expect to receive if they buy Walgreens.
The transaction closed and WBA common stock ceased public trading. Guaranteed cash: Former public WBA holders received $11.45 in cash per share as the primary, immediate merger consideration.
Though delisting does not affect your ownership, shares may not hold any value post-delisting. Thus, if any of the stocks that you own get delisted, it is better to sell your shares. You can either exit the market or sell it to the company when it announces buyback.
Deal terms and valuation.
Shareholders received $11.45 per share in cash, totaling about $9.9 billion based on Walgreens' 865 million outstanding shares. They may also receive up to an additional $3 per share from the monetization of Walgreens' stake in VillageMD, bringing the total deal value up to $23.7 billion. 2.
Walgreens (WBA) has been analyzed by 2 analysts, with a consensus rating of Sell. 0% of analysts recommend a Strong Buy, 0% recommend Buy, 50% suggest Holding, 0% advise Selling, and 50% predict a Strong Sell.
Experts from across the healthcare industry agree that while Walgreens is currently in a grim financial situation, recovery is still possible. To make this happen, the company will have to relinquish its retail clinic dreams and focus more on making its core pharmacy business as efficient as it can.
Walgreens: Don't Expect The Dividend To Come Back Anytime Soon (NASDAQ:WBA) | Seeking Alpha.
Usually, once the stocks are delisted, you receive either cash payment, or stocks of the new company, or both, or none in exchange for the shares you previously held.
If you miss the chance to sell during the delisting process, you can sell your shares to the promoter for at least one year after delisting at the same price. If you still don't sell, you can try selling your shares on the over-the-counter (OTC) market.
Yes, a delisted stock can come back and be relisted on a major exchange like the NYSE or Nasdaq, but it's often a difficult, lengthy process requiring the company to resolve the issues that caused the delisting (like low share price or financial non-compliance) and meet all exchange requirements again, though many don't successfully relist and end up trading on the less liquid over-the-counter (OTC) market or become worthless.
Each of your Walgreens shares were exchanged for $11.45 per share. This cash was deposited into your Cash App balance. You no longer own an interest in Walgreens or their acquirer, Sycamore Partners.
Walgreens is closing about 1,200 underperforming stores over three years, with roughly 500 slated for closure in their fiscal year 2025 (ending August 2025) as part of a cost-cutting "Footprint Optimization Program" due to financial pressures like decreased spending and competition. While a comprehensive list of all locations isn't released, specific closures occurred in cities like San Francisco, Macon, and Brooklyn, with many in May/June 2025, impacting states like California, Illinois, New Jersey, and North Carolina.
Walgreens: Growth Outlook and Valuation
Revenue is projected to grow 1.9% through 2027. Operating margins are expected to remain near 1.4% Shares trade at 6.7x forward earnings. Based on analysts average estimates, TIKR's Guided Valuation Model using a 6.7x forward P E suggests about $12/share by 2027.
In addition to their cash consideration of $11.45 per WBA share, WBA shareholders will receive one non-transferable right to receive up to an additional $3.00 in cash per WBA share from the net proceeds of the future monetization of WBA's debt and equity interests in VillageMD, which includes the Village Medical, ...
Walgreens is being taken private
To that end, Walgreens has agreed to be bought by Sycamore Partners. The deal is expected to close in the second half of 2025, with Walgreens shareholders getting $11.45 per share in cash. That's all that investors here can expect to receive if they buy Walgreens.
Trading Ends: Shares of WBA stock will be delisted after trading closes on August 27, 2025. No Future Ownership: Once private, investors will no longer own stock or have a say in Walgreens' direction.
Walgreens Boots Alliance
The company has not been performing particularly well for the last few years. While there's a potential turnaround opportunity for the business in the years ahead, that probably isn't going to translate into a big investment opportunity.